0001838216-21-000004.txt : 20210701 0001838216-21-000004.hdr.sgml : 20210701 20210701130535 ACCESSION NUMBER: 0001838216-21-000004 CONFORMED SUBMISSION TYPE: C-U PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210701 DATE AS OF CHANGE: 20210701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Grove Biomedical LLC CENTRAL INDEX KEY: 0001823771 IRS NUMBER: 850823430 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C-U SEC ACT: 1933 Act SEC FILE NUMBER: 020-27342 FILM NUMBER: 211065058 BUSINESS ADDRESS: STREET 1: 282 KATONAH AVENUE STREET 2: #537 CITY: KATONAH STATE: NY ZIP: 10546 BUSINESS PHONE: 6502040014 MAIL ADDRESS: STREET 1: 282 KATONAH AVENUE, #537 STREET 2: #537 CITY: KATONAH STATE: NY ZIP: 10546 C-U 1 primary_doc.xml C-U 0001823771 XXXXXXXX 020-27342 LIVE false false false The Offering closed successfully on 07.01.2021, having received investment commitments of $330,114.84, although a final accounting has not taken place. Grove Biomedical LLC Limited Liability Company NY 04-24-2020 282 KATONAH AVENUE, #537 #537 KATONAH NY 10546 https://www.onecanopy.com N OpenDeal Portal LLC 0001751525 007-00167 283874 The issuer shall pay to the Intermediary at the conclusion of the Offering a fee of six percent (6%) of the amount raised in the offering. The Intermediary will also receive compensation in the form of Securities equal to two percent (2%) of the total number of Securities sold in the Offering. Other Class CF Units 4457 5.61000 25003.77 Y Other At the Intermediary's discretion 1069995.30 06-30-2021 0.00 289694.00 0.00 126035.00 0.00 0.00 0.00 190813.00 0.00 296566.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -522685.00 0.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Grove Biomedical LLC Joseph Rosenberg CEO Joseph Rosenberg CEO 07-01-2021